Incyte (INCY) PT Lowered to $88 at RBC Capital
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts INCY Hot Sheet
Price: $122.64 +4.29%
Rating Summary:
19 Buy, 16 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 26 | New: 12
Rating Summary:
19 Buy, 16 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 26 | New: 12
Join SI Premium – FREE
RBC Capital analyst Brian Abrahams lowered the price target on Incyte (NASDAQ: INCY) to $88.00 (from $92.00) while maintaining a Sector Perform rating.
You May Also Be Interested In
- Incyte (INCY) PT Raised to $108 at Bernstein SocGen Group
- Incyte to Present New Data Highlighting Progress Across its Hematology Portfolio at ASH 2026
- Datadog (DDOG) PT Lowered to $285 at Rosenblatt
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
